Which is better, FOLD or JNJ?

On the Buffett-Fit framework, Johnson & Johnson (JNJ) currently grades higher than FOLD, 60/100 (C grade) vs 50/100 (C). That said, "better" depends on which framework you trust, FOLD wins on none; JNJ wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy FOLD or JNJ?

This page is an educational comparison, not investment advice. Both FOLD and JNJ are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most, and always do your own research before making any investment decision.

Is FOLD better than JNJ for value investing?

On the Buffett-style value-investing framework, JNJ currently grades higher, 60/100 vs 50/100, a 10-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between FOLD and JNJ on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). FOLD currently scores 50/100; JNJ scores 60/100. The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, FOLD or JNJ?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. FOLD and JNJ are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, FOLD or JNJ?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are FOLD and JNJ both Healthcare stocks?

Yes: both Amicus Therapeutics, Inc. (FOLD) and Johnson & Johnson (JNJ) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this FOLD vs JNJ comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria: they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Amicus Therapeutics

FOLD-Healthcare Market cap, Sector

Johnson & Johnson

JNJ$644.82BHealthcare Market cap, Sector

Overall winner

Johnson & Johnson

FOLD 06 JNJ

Fit scores by strategy

FOLD0wins

6winsJNJ

Warren Buffett

50D

C60

Benjamin Graham

50D

C67

Philip Fisher

50D

C64

Peter Lynch

50D

D52

Joel Greenblatt

50D

D50

Charlie Munger

50D

C64

Terry Smith

50D

D58

Side-by-side metrics

Metric	FOLD	JNJ
Market cap	-	$644.82B
P/E (TTM)	-	22.7x
EV/EBIT	-	19.0x
ROIC (TTM)	-	20.99%
Gross margin

More like FOLD

FOLD vs LLY FOLD vs ABBV FOLD vs RO.SW FOLD vs UNH

More like JNJ

JNJ vs LLY JNJ vs ABBV

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.

See the full analysis of Amicus Therapeutics vs Johnson & Johnson

The score, the checklist and the full reasoning open with a free account. You get 3 full analyses a week, and this stock is the first one. No card needed.

Create a free account

3 full analyses a week · no card needed

Already have an account? Sign in

JNJ vs FOLD: 60/100 vs 50/100 on Buffett-Fit · invest-like

See the full analysis of Amicus Therapeutics vs Johnson & Johnson

Key terms in this analysis